Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.
Autor: | Gori, S.1 mtonato@unipg.it, Colozza, M.1, Mosconi, A.M.1, Franceschi, E.2, Basurto, C.1, Cherubini, R.1, Sidoni, A.3, Rulli, A.4, Bisacci, C.4, de Angelis, V., Crinò, L.2, Tonato, M.1 |
---|---|
Zdroj: | British Journal of Cancer. 1/12/2004, Vol. 90 Issue 1, p36-40. 5p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |